FIELD: biotechnologies.
SUBSTANCE: invention relates to field of biotechnology, medicine and cellular biology. Claimed is method of differentiation of monocytic pre-cursors of dendritic cells into immature dendritic cells, as well as method of producing mature dendritic cells using colony-stimulating factor of granulocytes - macrophages GM-CSF without other cytokines under conditions which prevent cell adhesion to reservoir.
EFFECT: invention can be applied in immunotherapy based on dendritic cells, for instance, for application in treatment of diseases, including cancer.
22 cl, 15 dwg, 1 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
INTRODUCTION OF DENDRITIC CELLS EXPOSED TO PARTIAL AGING IN VITRO, FOR TUMOUR TREATMENT | 2003 |
|
RU2348418C2 |
METHODS RELATED TO ACTIVATED DENDRITIC CELLS COMPOSITIONS AND TO IMMUNOTHERAPEUTIC TREATMENT OF INDIVIDUALS WITH ADVANCED CANCER | 2016 |
|
RU2749610C2 |
CELL PRODUCT FOR LOADING AND ACTIVATION OF HUMAN DENDRITE CELLS | 2019 |
|
RU2714208C1 |
METHOD OF LOADING DENDRITIC CELLS WITH ANTIGEN OF INFECTIOUS ORIGIN Opistorchis felineus | 2011 |
|
RU2486238C1 |
IMMUNOTHERAPY OF BREAST CANCER USING ANTIGEN-ACTIVATED DENDRITIC CELLS | 2016 |
|
RU2645464C1 |
METHOD OF ENHANCEMENT OF IMMUNE RESPONSE TO ANTIGENE IN MAMMALS | 2004 |
|
RU2341289C2 |
METHOD FOR STIMULATING PRESENTING ACTIVITY OF DENDRITIC CELLS | 2019 |
|
RU2728592C1 |
METHOD OF OBTAINING STIMULATED DENDRITE CELLS FOR INDUCTION OF IMMUNE RESPONSE AGAINST HUMAN TUBERCULOSIS | 2009 |
|
RU2401664C1 |
METHOD FOR PRODUCING REGULATORY DENDRITIC CELLS | 2011 |
|
RU2597976C2 |
PHARMACEUTICAL COMPOSITION FOR INDUCING OF IMMUNE RESPONSE IN HUMAN | 2002 |
|
RU2313365C2 |
Authors
Dates
2009-08-20—Published
2004-02-27—Filed